Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 901–1,000 of 1,005
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI
Assmann, J. C., Farthing, D. E., Saito, K., Maglakelidze, N., Oliver, B., Warrick, K. A., Sourbier, C., Ricketts, C. J., Meyer, T. J., Pavletic, S. Z., et al. (2021) · Blood · doi:10.1182/blood.2020005770 · Cited by 36
Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer
Nisar, S., Bhat, A. A., Hashem, S., Yadav, S. K., Rizwan, A., Singh, M. K., Bagga, P., Macha, M. A., Frenneaux, M. P., Reddy, R. D., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02656-7 · Cited by 38
Tay, C., Qian, Y., & Sakaguchi, S. (2020) · Cancers · doi:10.3390/cancers13010048 · Cited by 38
“the transport of acyl-CoA into mitochondria for fatty acid oxidation (FAO) [38,39].”
BackgroundInfluentialChen, X., Li, S., Long, D., Shan, J., & Li, Y. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104378 · Cited by 40
Impact of Lipid Metabolism on Antitumor Immune Response
Mabrouk, N., Lecoeur, B., Bettaïeb, A., Paul, C., & Végran, F. (2022) · Cancers · doi:10.3390/cancers14071850 · Cited by 37
“The metabolic requirement for CD4 effector T cells (Teff) Th1, Th2, Th9, Th17 and Tfh is mainly supplied through an aerobic glycolysis process, as in cytotoxic CD8+ cells, while regulatory CD4+ T cells (Tregs) or exhausted CD8+ cells mainly rely on FAO [62].”
BackgroundDas, U. N. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01173-8 · Cited by 39
“In this context, it is noteworthy that Treg cells rely on lipid metabolism for their survival and function [51, 52].”
BackgroundLactate Dehydrogenase Inhibition: Exploring Possible Applications Beyond Cancer Treatment
Stefano, G. D., Manerba, M., Ianni, L. D., & FIUME, L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.16.10 · Cited by 38
Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells
Lü, J., Liang, Y., Meng, H., Zhang, A., Zhao, J., & Zhang, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728783 · Cited by 40
Immunometabolic reprogramming, another cancer hallmark
Kumar, V., & Stewart, J. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125874 · Cited by 37
Energy competition remodels the metabolic glucose landscape of psoriatic epidermal cells
Liu, W., Jiang, J., Li, Z., Xiao, Y., Zhou, S., Wang, D., Zou, Y., Liu, T., Li, K., Liang, H., et al. (2024) · Theranostics · doi:10.7150/thno.93764 · Cited by 43
Masson, J. J. R., Murphy, A. J., Lee, M. K. S., Ostrowski, M., Crowe, S. M., & Palmer, C. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183931 · Cited by 37
“The general consensus is that effector T cells are generally more glycolytic [12,30,31] while memory and naïve T cells rely on oxidative phosphorylation and fatty acid metabolism [32,33].”
BackgroundSurvival of the fittest: Cancer challenges T cell metabolism
Franchina, D. G., HeFeng, F. Q., & Brenner, D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.014 · Cited by 35
The regulation effect of AMPK in immune related diseases
Wang, J., Li, Z., Gao, L., Qi, Y., Zhu, H., & Qin, X. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9169-6 · Cited by 39
Early-life undernutrition reprograms CD4+ T-cell glycolysis and epigenetics to facilitate asthma
Chen, X., Lin, H., Yang, D., Xu, W., Liu, G., Liu, X., Sheng, J., & Huang, H. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.999 · Cited by 38
Metabolism and Autoimmune Responses: The microRNA Connection
Colamatteo, A., Micillo, T., Bruzzaniti, S., Fusco, C., Garavelli, S., Rosa, V. D., Galgani, M., Spagnuolo, M. I., Rella, F. D., Puca, A. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01969 · Cited by 43
Magalhaes, I., Yogev, O., Mattsson, J., & Schurich, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02309 · Cited by 36
Relevance of the Warburg Effect in Tuberculosis for Host-Directed Therapy
Cumming, B. M., Pacl, H. T., & Steyn, A. J. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.576596 · Cited by 37
“Furthermore, distinct metabolic programs differentiate T cells into their lineages and determine their effector functions, for example, Th1, Th2, and Th17 cells rely strongly on glycolysis (Michalek et al., 2011).”
BackgroundThe Ups and Downs of Metabolism during the Lifespan of a T Cell
Balyan, R., Gautam, N., & Gascoigne, N. R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217972 · Cited by 37
“However, amongst these subsets, Th2 has been classified as the most glycolytic and shows the highest expression of Glut1 [64,81].”
BackgroundInfluentialHematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions
Montironi, C., Muñoz‐Pinedo, C., & Eldering, E. (2021) · Cancers · doi:10.3390/cancers13020284 · Cited by 40
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation
Contreras, D. C., Cephus, J. Y., Barone, S. M., Chowdhury, N. U., Dahunsi, D. O., Madden, M. Z., Ye, X., Yu, X., Olszewski, K. L., Young, K. L., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001029 · Cited by 33
“As previously described, both Th2 and Th17 cells used distinct metabolic programs and metabolite profiles from naive CD4 T cells and each other (8, 9).”
BackgroundSelf-citationImmunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance
Traba, J., Sack, M. N., Waldmann, T. A., & Antón, O. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657293 · Cited by 43
“In the case of T cells, lipid accumulation supports Treg function, which relies on FAO to fuel OxPhos (131).”
BackgroundImmunometabolism: Towards a Better Understanding the Mechanism of Parasitic Infection and Immunity
Chen, J.-Y., Zhou, J., & Pan, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661241 · Cited by 48
Xia, M., Zhang, C., Chen, Y. A., Zhao, X., Zhang, S., Liu, Y., Cai, Y., Wei, Z., Du, Q., Yu, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205469119 · Cited by 38
Semeniuk-Wojtaś, A., Poddębniak-Strama, K., Modzelewska, M., Baryła, M., Dziąg-Dudek, E., Syryło, T., Górnicka, B., Jakieła, A., & Stec, R. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03376-9 · Cited by 35
“In contrast, Tregs do not seem to be sensitive to lactate and acidification [119, 133].”
BackgroundMetabolic Factors that Contribute to Lupus Pathogenesis
Li, W., Sivakumar, R., Titov, A. A., Choi, S., & Morel, L. M. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016017164 · Cited by 36
Lipid-mediated regulation of the cancer-immune crosstalk
Ma, Y., Zhang, S., Jin, Z., & Shi, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105131 · Cited by 38
Maya, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511937 · Cited by 41
“Different subsets of T cells can rely on specific metabolic pathways based on their effector or suppressive functional state—CD4+ helper cells rely on glycolysis for their effector function, whereas regulatory T cells (Tregs) depend on fatty acids to fuel antiinflammatory responses (Figure 2) [70,71].”
BackgroundKanekura, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417344 · Cited by 33
“Th1, Th2, and Th17 cells express high surface levels of GLUT-1 and are highly glycolytic [56].”
BackgroundAntiobesity Effect of a Small Molecule Repressor of RORγ
Chang, M. R., He, Y., Khan, T. M., Kuruvilla, D. S., Garcia-Ordoñez, R. D., Corzo, C. A., Unger, T. J., White, D. W., Khan, S., Lin, L., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097485 · Cited by 37
“Previously, it was shown that in cultured cells SR1555 repressed TH17 cell differentiation with concomitant expansion of inducible Tregs (Solt et al., 2012), and induction of Tregs has been shown to be associatedwithmetabolic disorders (Michalek et al., 2011; Bhat et al., 2014).”
Binger, K. J., Côrte‐Real, B. F., & Kleinewietfeld, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00311 · Cited by 38
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Targeting T Cell Metabolism in Inflammatory Skin Disease
von Meyenn, L., Bertschi, N., & Schlapbach, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02285 · Cited by 33
Differential effects of 2-deoxy-D-glucose on in vitro expanded human regulatory T cell subsets
Tanimine, N., Germana, S. K., Fan, M. Y., Hippen, K. L., Blazar, B. R., Markmann, J. F., Turka, L. A., & Priyadharshini, B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217761 · Cited by 41
Integrative computational approach identifies drug targets in CD4+ T-cell-mediated immune disorders
Puniya, B. L., Amin, R., Lichter, B., MOORE, R. E., Ciurej, A., Bennett, S. J., Shah, A. R., Barberis, M., & Helikar, T. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-020-00165-3 · Cited by 36
Metabolic profiles of regulatory T cells in the tumour microenvironment
Rao, D., Verburg, F., Renner, K., Peeper, D. S., Lacroix, R., & Blank, C. U. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02881-z · Cited by 221
Sirtuins as Metabolic Regulators of Immune Cells Phenotype and Function
Fortuny, L., & Sebastián, C. (2021) · Genes · doi:10.3390/genes12111698 · Cited by 38
Kokkinou, E., Pandey, R. V., Mazzurana, L., Gutiérrez-Pérez, I., Tibbitt, C. A., Weigel, W., Soini, T., Carrasco, A., Rao, A., Nagasawa, M., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abj8301 · Cited by 42
McTernan, P. M., Levitt, D. E., Welsh, D. A., Simon, L., Siggins, R. W., & Molina, P. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839390 · Cited by 39
Soriano‐Baguet, L., Grusdat, M., Kurniawan, H., Benzarti, M., Binsfeld, C., Ewen, A., Longworth, J., Bonetti, L., Guerra, L., Franchina, D. G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112153 · Cited by 37
Sung, M. S., Li, Z., Cui, L., Choi, J. S., Choi, W. S., Park, M. J., Park, S. H., & Yoon, K. C. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16153 · Cited by 34
He, X., Koenen, H. J. P. M., Smeets, R. L., Keijsers, R., van Rijssen, E., Koerber, A., van de Kerkhof, P. C., Boots, A. M. H., & Joosten, I. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.459 · Cited by 33
“This is underlined by the phenomenon that effector T cells and Treg require distinct metabolic programs to support their functions; Th1, Th2, and Th17 cells are highly glycolytic, whereas Treg have high lipid oxidation rates in vitro (Michalek et al., 2011).”
BackgroundEffects of PD-1 Signaling on Immunometabolic Reprogramming
Boussiotis, V. A., & Patsoukis, N. (2022) · Immunometabolism · doi:10.20900/immunometab20220007 · Cited by 41
“Since PD-1 engagement inhibits the PI3K/Akt pathway on effector T cells [26,31,46], and promotes lipid oxidation [39], a preferred metabolic pathway in Treg cells [66], it would be anticipated that genetic ablation of PD-1 in Treg would enhance activation of the PI3K/Akt pathway and glycolysis.”
BackgroundTargeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
Wang, B., Zhang, Z., Liu, W., & Tan, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114180 · Cited by 41
Immune Resistance Mechanisms and the Road to Personalized Immunotherapy
Piper, M., Kluger, H. M., Ruppin, E., & Hu‐Lieskovan, S. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390290 · Cited by 43
Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies
Feng, L., Chen, X., Huang, Y., Zhang, X., Zheng, S., & Xie, N. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1243675 · Cited by 40
“Compared to Th1 and Th17 cells with high levels of glycolysis and low levels of FAO, Tregs with a low level of GLUT1 have a higher rate of lipid oxidation to fuel the mitochondrial, ETC for proliferation and differentiation (Michalek et al., 2011).”
BackgroundMetabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
Zhao, L., Ma, D., Wang, L., Su, X., Feng, L., Zhu, L., Chen, Y., Hao, Y., Wang, X., & Feng, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1301051 · Cited by 37
Deciphering the relationship between temperature and immunity
Maloney, E., & Duffy, D. (2024) · Discovery Immunology · doi:10.1093/discim/kyae001 · Cited by 44
“Temperatures as low as 38.5°C selectively enhance T cell differentiation to the proinflammatory T-helper 17 (Th17) subtype almost 2-fold ex vivo [25, 100, 101].”
BackgroundInfluentialFerroptosis of T cell in inflammation and tumour immunity
Xia, X., Wu, H., Chen, Y., Peng, H., & Wang, S. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70253 · Cited by 34
The Role of Fatty Acid Oxidation in the Metabolic Reprograming of Activated T-Cells
Byersdorfer, C. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00641 · Cited by 35
Park, J., Moon, S., Lim, M., Byun, J. K., Hwang, S., Yang, S., Kim, E., Lee, H., Kim, S., Lee, J. J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02270 · Cited by 34
Acsbg1 Dependent Mitochondrial Fitness is a Metabolic Checkpoint for Tissue T reg Cell Homeostasis
Kanno, T., Nakajima, T., Kawashima, Y., Yokoyama, S., Asou, H. K., Sasamoto, S., Hayashizaki, K., Kinjo, Y., Ohara, O., Nakayama, T., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109921 · Cited by 39
NAMPT is a metabolic checkpoint of IFNγ-producing CD4+ T cells in lupus nephritis
Li, M., Lai, Y., Chen, B., Guo, C., Zhou, M., Zhao, S., Wang, S., Li, J., Yang, N., & Zhang, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.013 · Cited by 32
New insights into the metabolism of Th17 cells
Kono, M. (2022) · Immunological Medicine · doi:10.1080/25785826.2022.2140503 · Cited by 37
Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate
Muroski, M. E., Miska, J. M., Chang, A. L., Zhang, P., Rashidi, A., Moore, H. C., Lopez‐Rosas, A., Han, Y., & Lesniak, M. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-05556-x · Cited by 37
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
Shirakawa, K., & Sano, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1044737 · Cited by 38
Caloric restriction for the immunometabolic control of human health
Procaccini, C., de Candia, P., Russo, C., Rosa, G. D., Lepore, M. T., Colamatteo, A., & Matarese, G. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad035 · Cited by 37
Brescia, C., Audia, S., Pugliano, A., Scaglione, F., Iuliano, R., Trapasso, F., Perrotti, N., Chiarella, E., & Amato, R. (2024) · Apmis · doi:10.1111/apm.13378 · Cited by 34
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
Shan, Y., Xie, T., Sun, Y., Lu, Z., Topatana, W., Juengpanich, S., Chen, T., Han, Y., Cao, J., Hu, J., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00588-8 · Cited by 37
Gut redox and microbiome: charting the roadmap to T-cell regulation
Prasad, S., Singh, S., Menge, S., Mohapatra, I., Kim, S., Helland, L. C., Singh, G., & Singh, A. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387903 · Cited by 38
Lo, Y.-C., Lee, C.-F., & Powell, J. D. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000098 · Cited by 34
“As mentioned above, effector T cells employ aerobic glycolysis for energy whereas Tregs employ oxidative phosphorylation and fatty acid oxidation [86].”
BackgroundKuczma, M., Ding, Z., & Zhou, G. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016017507 · Cited by 37
Immune Cell Metabolism in Tumor Microenvironment
Li, Y., Wan, Y. Y., & Zhu, B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_5 · Cited by 37
What’s new in IBD therapy: An “omics network” approach
Fiocchi, C., & Iliopoulos, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104886 · Cited by 35
IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection
de, M. M., Rivera, F. D. L., Winterford, C. M., Frame, T. C. M., Ng, S. S., Amante, F. H., Edwards, C. L., Bukali, L., Wang, Y., Uzonna, J. E., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008994 · Cited by 34
Lv, Q., Yao, X., Dong, D., Hu, Y., Chen, Q., Zhai, L., Hu, L., & Zhang, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107688 · Cited by 41
Dallio, M., Romeo, M., Gravina, A. G., Masarone, M., Larussa, T., Abenavoli, L., Persico, M., Loguercio, C., & Federico, A. (2021) · Nutrients · doi:10.3390/nu13051679 · Cited by 33
García‐Cañaveras, J. C., & Lahoz, A. (2021) · Cancers · doi:10.3390/cancers13133230 · Cited by 38
Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism
Li, W., Gong, M., Park, Y. P., Elshikha, A. S., Choi, S., Brown, J., Kanda, N., Yeh, W.-I., Peters, L. D., Titov, A. A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143540 · Cited by 36
“Another orphan nuclear receptor, Esrra, promotes T cell effector functions through glucose metabolism (72).”
BackgroundDing, Y., Lin, H., Chen, X., Zhu, B., Xu, X., Xu, X., Shen, W., Gao, M., & He, N. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103548 · Cited by 34
“…were disturbed between HIV+ NCs vs HIV (cid:1) NCs, and between HIV+ NCI and HIV+ LF vs HIV (cid:1) NCs. HIV infection causes long-lasting activation of the immune system along with increasing energy expenditure, resulting in widespread changes in cell metabolism and amino acid levels [6,35,36].”
The Skewed Balance Between Tregs and Th17 in Chronic Lymphocytic Leukemia
Yousefi, M., Movassaghpour, A. A., Shamsasenjan, K., Ghalamfarsa, G., Sadreddini, S., Jadidi‐Niaragh, F., & Hojjat‐Farsangi, M. (2015) · Future Oncology · doi:10.2217/fon.14.298 · Cited by 39
Hypoxic culture conditions enhance the generation of regulatory T cells
Neildez‐Nguyen, T. M. A., Bigot, J., Rocha, S. D., Corre, G., Boisgérault, F., Páldi, A., & Galy, A. H. M. (2015) · Immunology · doi:10.1111/imm.12388 · Cited by 37
The immune diet: meeting the metabolic demands of lymphocyte activation
Wang, R., & Green, D. R. (2012) · F1000 Biology Reports · doi:10.3410/b4-9 · Cited by 35
“Of these, only the Treg cells rely on lipid oxidation as an energy source, and forcing proliferating T cells to utilize free fatty acids for energy tends to drive enhanced Treg differentiation [10].”
BackgroundImmune cell metabolism in autoimmunity
Teng, X., Li, W., Cornaby, C., & Morel, L. M. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13277 · Cited by 34
A Stk4-Foxp3–NF-κB p65 transcriptional complex promotes T reg cell activation and homeostasis
Cui, Y., Benamar, M., Schmitz‐Abe, K., Krishnan, V. P., Chen, Q., Jugder, B., Fatou, B., Fong, J. J. H., Zhong, Y., Mehta, S., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl8357 · Cited by 33
Dong, S., Li, W., Li, X., Wang, Z., Zhou, C., Shi, H., He, R., Chen, C., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038650 · Cited by 39
Immunosurveillance encounters cancer metabolism
Chuang, Y., Tzeng, S., Ho, P., & Tsai, C. (2024) · EMBO Reports · doi:10.1038/s44319-023-00038-w · Cited by 34
“KSUCC Succinylated Lysine, FA fatty acid, FAO fatty acid oxidation, TAM tumor-associated macrophage, 2OG 2-oxoglutarate, HRE HIF-responsive element.”
BackgroundInfluentialCorrado, M., Scorrano, L., & Campello, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8727 · Cited by 35
“Regulatory T cells play an important role in shaping an immunosuppressive environment in the tumour [2] and they have been shown to metabolically rely on fatty acid oxidation [134],[135], as well as on glycolysis, in conditions different than cancer [136].”
BackgroundLi, T., Wang, W., Gong, S., Sun, H., Zhang, H., Yang, A., Chen, Y. H., & Li, X. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.05.007 · Cited by 36
Expression of Hypoxia-Inducible Factor 1α (HIF-1α) and Genes of Related Pathways in Altered Gravity
Vogel, J., Thiel, C. S., Tauber, S., Stockmann, C., Gassmann, M., & Ullrich, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020436 · Cited by 36
“HIF-1 drives the expression of a number of genes necessary for the shift to a glycolysis dominated metabolism [27,28], resulting in metabolic reprogramming of T cells [29,30].”
BackgroundBalancing STAT Activity as a Therapeutic Strategy
Polak, K. L., Chernosky, N. M., Smigiel, J. M., Tamagno, I., & Jackson, M. W. (2019) · Cancers · doi:10.3390/cancers11111716 · Cited by 31
T Cell Metabolism in Cancer Immunotherapy
Aksoylar, H., Tijaro-Ovalle, N. M., Boussiotis, V. A., & Patsoukis, N. (2020) · Immunometabolism · doi:10.20900/immunometab20200020 · Cited by 32
“Treatment with cytokines IL-7 or IL-15 would promote lipid metabolism towards FAO to favor memory T cell phenotype [51,52,140,141].”
BackgroundInfluentialAging and Immunometabolic Adaptations to Thermogenesis
Lettieri‐Barbato, D., & Aquilano, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101143 · Cited by 35
“Limitation of glucose uptake by 2‑deoxyglucose (2DG) inhibited macrophage activation in vitro and dampened inflammation in in vivo models (Hamilton et al., 1986; Michl et al., 1976).”
BackgroundXu, C., Fu, Y., Liu, S., Trittipo, J., Lu, X., Qi, R. A., Du, H., Yan, C., Zhang, C., Wan, J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001184 · Cited by 34
Metabolism as a driver of immunity
Pearce, E. L. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00601-3 · Cited by 33
Qin, J., Liu, Q., Liu, A. A., Leng, S., Wang, S., Li, C., Ma, J., Peng, J., & Xu, M. (2022) · British Journal of Haematology · doi:10.1111/bjh.18293 · Cited by 36
“The inhibition of FAS can impair the proliferation of Teff,(38,39) while Tregs rely on the FAO as energy resource.(15) Acetyl CoA produced by FAO can be transferred into mitochondria for oxidative phosphorylation, which contributes to the OCR to some extent.”
BackgroundCharacterization of the effect of the GLUT-1 inhibitor BAY-876 on T cells and macrophages
Chen, Z., Vaeth, M., Eckstein, M., Delgobo, M., Ramos, G. C., Frantz, S., Hofmann, U., & Gladow, N. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175552 · Cited by 36
Michaels, M., & Madsen, K. L. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.001 · Cited by 37
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 37
KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging
Soto‐Heredero, G., Gabandé‐Rodríguez, E., Carrasco, E., Escrig-Larena, J. I., Heras, M. M. G. D. L., Delgado-Pulido, S., Francos-Quijorna, I., Blanco, E. M., Fernández-Almeida, Á., Abia, D., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00855-9 · Cited by 37
“IL-33 is an interleukin-1-like cytokine that plays a critical role in mucosal immunity, favoring Th2 differentiation 53 .”
InfluentialWu, G., Fan, X., Cheng, L., Chen, Z., Yi, Y., Liang, J., Huang, X., Yang, N., Yin, J., Guo, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx6489 · Cited by 43
“Restricting glycolysis and favoring a shift toward OxPhos are crucial for the differentiation and function of T reg cells, underscoring the distinct metabolic requirements that govern the functions of T eff and T reg cells ( 6 , 35 ).”
A role for Peroxisome Proliferator-Activated Receptor Beta in T cell development
Mothe‐Satney, I., Murdaca, J., Sibille, B., Rousseau, A., Squillace, R., Menn, G. L., Rekima, A., Larbret, F., Pelé, J., Verhasselt, V., et al. (2016) · Scientific Reports · doi:10.1038/srep34317 · Cited by 32
TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway
Jin, S., Liao, Q., Chen, J., Zhang, L., He, Q., Zhu, H., Zhang, X., & Xu, J. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0139-5 · Cited by 32
PPARs and the Development of Type 1 Diabetes
Holm, L. J., Mønsted, M. Ø., Haupt‐Jorgensen, M., & Buschard, K. (2020) · PPAR Research · doi:10.1155/2020/6198628 · Cited by 38
“In this way, T cell differentiation can be manipulated as inhibition of glycolysis blocks Th17 and promotes Treg differentiation [51].”
BackgroundD-mannose ameliorates autoimmune phenotypes in mouse models of lupus
Wang, H., Teng, X., Abboud, G., Li, W., Ye, S., & Morel, L. M. (2021) · BMC Immunology · doi:10.1186/s12865-020-00392-7 · Cited by 30
Costa, F., Marchica, V., Storti, P., Malavasi, F., & Giuliani, N. (2021) · Cancers · doi:10.3390/cancers13020164 · Cited by 33
“This event then polarizes T cells towards a regulatory and exhausted phenotype [29].”
BackgroundPharmacological inhibition of GLUT1 as a new immunotherapeutic approach after myocardial infarction
Chen, Z., Dudek, J., Maack, C., & Hofmann, U. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114597 · Cited by 34
The role of metabolism in Th17 cell differentiation and autoimmune diseases
Wang, G., Su, Z., Li, H. J., Xiao, L., Li, C., & Lian, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108450 · Cited by 30
Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity
de Gruil, N., Pijl, H., van der Burg, S. H., & Kroep, J. R. (2022) · Cancers · doi:10.3390/cancers14061390 · Cited by 32
“STF increases adenosine monophosphate-activated protein kinase (AMPK) pathway activity, which can promote long-term survival and lineage stability through fatty acid oxidation [44,45].”
BackgroundKim, S., Koh, J., Song, S. G., Yim, J., Kim, M., Keam, B., Kim, Y. T., Kim, J., Chung, D. H., & Jeon, Y. K. (2022) · BMC Cancer · doi:10.1186/s12885-022-10239-6 · Cited by 33
Gurram, R. K., Kujur, W., Maurya, S. K., & Agrewala, J. N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545871 · Cited by 30
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.